Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus.

OBJECTIVE To assess the prevalence of sleep apnea (SA) in adults with type 2 diabetes mellitus (T2DM) and examine whether demographics and comorbid factors were associated with SA in this population. METHODS This study enrolled 330 consecutive adults with T2DM referred to a diabetes clinic, 279 of whom completed the study. Evaluation of the presence of SA was performed with use of a single-channel recording device that measures disordered breathing events from a nasal cannula airflow signal. The device was worn by the study participants in their home, after instruction in appropriate use by clinical staff at the diabetes center. The presence and severity of SA were determined by use of an apnea-hypopnea index (AHI), reflecting periods of diminished and absent breathing. Demographic and medical information data were collected to detect factors associated with SA in this study population. In addition, a time and cost analysis was conducted regarding the screening process for SA by clinical staff at the diabetes center. RESULTS The results show a high prevalence of SA in adults with T2DM, ranging from 48% (AHI level of >or=10 events/h) to 29% (AHI level of >or=20 events/h). At an AHI cutoff value of >or=15 events/h, the overall prevalence rate was 36% (49% in male and 21% in female participants). The following variables were associated with SA: age >or=62 years, male sex, body mass index >or=30 kg/m2, snoring, and reports of stopping breathing during sleep. The time and cost analysis showed that the screening device involved minimal setup time, was simple to use, and was a cost-effective method to screen for SA. CONCLUSION SA is a common disorder associated with major morbid conditions, including hypertension, obesity, cardiovascular disease, and insulin resistance. Predisposing factors for SA and T2DM are similar. This study showed that SA has a high prevalence in adults with T2DM and identified factors that may be associated with its presence in this population. Assessment for SA can be easily performed in an outpatient setting with a portable recording device such as the one used in this study. Screening for SA should be considered in the T2DM population.

[1]  H. Yaggi,et al.  Sleep duration as a risk factor for the development of type 2 diabetes. , 2006, Diabetes care.

[2]  J. Samet,et al.  The Sleep Heart Health Study: design, rationale, and methods. , 1997, Sleep.

[3]  K. Lam,et al.  Obstructive sleep apnea is independently associated with insulin resistance. , 2002, American journal of respiratory and critical care medicine.

[4]  J. Ficker,et al.  The Effect of Continuous Positive Airway Pressure Treatment on Insulin Sensitivity in Patients with Obstructive Sleep Apnoea Syndrome and Type 2 Diabetes , 2004, Respiration.

[5]  Terry Young,et al.  Association of sleep apnea and type II diabetes: a population-based study. , 2005, American journal of respiratory and critical care medicine.

[6]  Erry,et al.  Prospective study of the association between sleep-disordered breathing and hypertension. , 2000, The New England journal of medicine.

[7]  D. Einhorn,et al.  Validation of the ApneaLink for the screening of sleep apnea: a novel and simple single-channel recording device. , 2007, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[8]  T. Weaver,et al.  Insulin Resistance and Obstructive Sleep Apnea: Is Increased Sympathetic Stimulation the Link? , 2003, Biological research for nursing.

[9]  T. Okada,et al.  High incidence of sleep apnea syndrome in a male diabetic population. , 1991, Diabetes research and clinical practice.

[10]  K. Flegal,et al.  Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.

[11]  F. J. Nieto,et al.  The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study. , 2001, Sleep.

[12]  Zhang Jing-xing,et al.  Brief introduction to second edition of International Classification of Sleep Disorders:Diagnostic and Coding Manual , 2007 .

[13]  J. Stradling,et al.  Neck circumference and other clinical features in the diagnosis of the obstructive sleep apnoea syndrome. , 1992, Thorax.

[14]  ColinE. Sullivan,et al.  REVERSAL OF OBSTRUCTIVE SLEEP APNOEA BY CONTINUOUS POSITIVE AIRWAY PRESSURE APPLIED THROUGH THE NARES , 1981, The Lancet.

[15]  F. J. Nieto,et al.  Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. , 1999, American journal of respiratory and critical care medicine.

[16]  J. Hedner,et al.  Snoring and sleep apnoea in men: association with central obesity and hypertension. , 1993, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[17]  T. Rephann,et al.  Association , 1973, ACM SIGSPATIAL International Workshop on Advances in Geographic Information Systems.

[18]  Terry Young,et al.  Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. , 2002, Archives of internal medicine.

[19]  Thomas Penzel,et al.  Effect of Nasal Continuous Positive Airway Pressure Treatment on Blood Pressure in Patients With Obstructive Sleep Apnea , 2003, Circulation.

[20]  N. Punjabi,et al.  Sleep-disordered breathing, glucose intolerance, and insulin resistance , 2003, Respiratory Physiology & Neurobiology.

[21]  J. Manson,et al.  Snoring as a risk factor for type II diabetes mellitus: a prospective study. , 2002, American journal of epidemiology.

[22]  T. Gislason,et al.  The role of habitual snoring and obesity in the development of diabetes: a 10‐year follow‐up study in a male population , 2000, Journal of internal medicine.

[23]  P. Cistulli,et al.  Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. , 1994, The Journal of clinical endocrinology and metabolism.

[24]  J. Ficker,et al.  Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. , 2004, American journal of respiratory and critical care medicine.

[25]  K. Spiegel,et al.  Impact of sleep debt on metabolic and endocrine function , 1999, The Lancet.

[26]  Anne Newman,et al.  Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. , 2003, Diabetes care.

[27]  D. Papanicolaou,et al.  Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. , 2000, The Journal of clinical endocrinology and metabolism.

[28]  P. Giraud,et al.  Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome , 2003, European Respiratory Journal.

[29]  T. Gislason,et al.  Sleep‐disordered breathing and glucose metabolism in hypertensive men: a population‐based study , 2001, Journal of internal medicine.

[30]  S. Redline,et al.  Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. , 2004, American journal of epidemiology.

[31]  T. Young,et al.  Epidemiology of obstructive sleep apnea: a population health perspective. , 2002, American journal of respiratory and critical care medicine.

[32]  J. Sorkin,et al.  Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. , 2002, American journal of respiratory and critical care medicine.

[33]  H. Teschler,et al.  [Validation of microMESAM as screening device for sleep disordered breathing]. , 2003, Pneumologie.

[34]  S. Shott,et al.  Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. , 2005, Archives of internal medicine.